Bahnemann E, Kerling H P, Ensminger S, Schwerdt G, Silbernagl S, Gekle M
Physiologisches Institut, Universität Würzburg, Germany.
Toxicology. 1997 Jun 6;120(1):11-7. doi: 10.1016/s0300-483x(97)03625-1.
Renal excretion is an important way of elimination for the nephrotoxin ochratoxin A (OTA). Because binding to proteins hinders filtration, excretion is mainly due to proximal tubular secretion. The goal of this study was to investigate the kinetics of secretion as well as the extent of urine and tissue accumulation in situ using the non-filtering amphibian kidney model. Transepithelial secretion is a saturable process (K(m) = 0.63.10(-6) mol/l) and leads to a concentration-dependent accumulation of OTA in the tubular lumen and in renal tissue. Maximum accumulation achieved is approximately 14-fold as compared to the perfusate concentration. There was no accumulation in the tubular lumen as compared to renal tissue (lumen-to-tissue concentration ratio approximately 1). Tissue and tubular lumen accumulation were reduced to approximately 40% of control in the presence of 10(-3) mol/l p-aminohippurate (PAH). Addition of 10(-3) mol/l alpha-ketoglutarate (KG) to PAH-containing perfusate did not lead to a further reduction of secretion. By contrast, addition of 10(-2) mol/l L-phenylalanine (L-Phe) reduced secretion further to approximately 25% of control. In the presence of 10(-3) mol/l probenecid tissue accumulation was reduced to 7% and tubular lumen accumulation to 1% of control. Lumen-to-tissue concentration ratio decreased to 0.15 in the presence of probenecid, indicating an inhibitory action at the luminal membrane. Addition of albumin to the perfusate, reduced secretion to only 50% of control, whereas the concentration of free OTA was reduced below 1% as compared to control. The results of this study show that transepithelial secretion is an effective way for accumulation of OTA in the tubular lumen and thus its urinary excretion. Transport via the basolateral organic anion and a basolateral amino acid carrier are the active steps in transepithelial secretion. Luminal exit of OTA is a passive process. Furthermore, tissue accumulation by the active transport across the basolateral membrane supports the toxic action of OTA on proximal tubular cells. Due to the qualitative similarity of organic anion transport our findings should also apply for the mammalian kidney.
肾脏排泄是肾毒素赭曲霉毒素A(OTA)的重要消除途径。由于与蛋白质结合会阻碍滤过,排泄主要是由于近端肾小管分泌。本研究的目的是使用非滤过性两栖动物肾脏模型研究分泌动力学以及原位尿液和组织蓄积程度。跨上皮分泌是一个饱和过程(K(m)=0.63×10⁻⁶mol/L),会导致OTA在肾小管腔和肾组织中呈浓度依赖性蓄积。与灌注液浓度相比,最大蓄积量约为14倍。与肾组织相比,肾小管腔内没有蓄积(管腔与组织浓度比约为1)。在存在10⁻³mol/L对氨基马尿酸(PAH)的情况下,组织和肾小管腔蓄积减少至对照的约40%。向含PAH的灌注液中添加10⁻³mol/Lα-酮戊二酸(KG)并未导致分泌进一步减少。相比之下,添加10⁻²mol/L L-苯丙氨酸(L-Phe)会使分泌进一步减少至对照的约25%。在存在10⁻³mol/L丙磺舒的情况下,组织蓄积减少至对照的7%,肾小管腔蓄积减少至对照的1%。在丙磺舒存在下,管腔与组织浓度比降至0.15,表明对管腔膜有抑制作用。向灌注液中添加白蛋白,分泌减少至对照的仅50%,而游离OTA的浓度与对照相比降低至1%以下。本研究结果表明,跨上皮分泌是OTA在肾小管腔中蓄积从而实现其经尿液排泄的有效途径。通过基底外侧有机阴离子转运以及基底外侧氨基酸载体转运是跨上皮分泌的活性步骤。OTA的管腔排出是一个被动过程。此外,通过基底外侧膜的主动转运导致的组织蓄积支持了OTA对近端肾小管细胞的毒性作用。由于有机阴离子转运的定性相似性,我们的发现也应适用于哺乳动物肾脏。